Categories
Cancer Clinical trials Medicine Science

Clinical trials do still work, but need to evolve

As I write this, I’m winging my way home from TAM, crammed uncomfortably—very uncomfortably—in a window seat in steerage—I mean, coach). I had thought of simply recounting the adventures of the contingent of skeptics with whom I’m associated who did make it out to TAM to give talks at workshops and the main stage and […]

Categories
Cancer Complementary and alternative medicine Medicine Quackery

Acupuncture and breast cancer-related lymphedema: Quackademia strikes again

Lymphedema is a complication of breast cancer surgery that all surgeons who do breast surgery detest. Patients, of course, detest it even more. The limb swelling that is the primary symptom of lymphedema comes about because surgery on the axillary lymph nodes (the lymph nodes under the arm) that is part and parcel of surgery […]

Categories
Cancer Complementary and alternative medicine Movies Quackery Skepticism/critical thinking

The quack view of preventing breast cancer versus reality and Angelina Jolie, part 2

After yesterday, I really hadn’t planned on writing about Angelina Jolie and her decision to undergo bilateral mastectomies again, except perhaps as a more serious piece next week on my not-so-super-secret other blog where The Name of the Doctor is revealed on a weekly basis. As I mentioned yesterday, there are a number of issues […]

Categories
Cancer Clinical trials Complementary and alternative medicine Medicine Skepticism/critical thinking

Deconstructing another Stanislaw Burzynski cancer “success story”

A key pillar of the Stanislaw Burzynski antineoplaston marketing machine, a component of the marketing strategy without which his clinic would not be able to attract nearly as many desperate cancer patients to Houston for either his antineoplaston therapy (now under a temporary shutdown by the FDA that, if science were to reign, will become […]

Categories
Cancer Clinical trials Medicine

No, the New York Times did not “kill your patient.”

One of the more depressing things about getting much more interested in the debate over how we should screen for common cancers, particularly breast and prostate cancer, is my increasing realization of just how little physicians themselves understand about the complexities involved in weighing the value of such tests. It’s become increasingly apparent to me […]